✦ LIBER ✦

Commentary on: Everolimus for Angiomyolipoma Associated With Tuberous Sclerosis Complex or Sporadic Lymphangioleiomyomatosis (EXIST-2): A Multicentre, Randomised, Double-blind, Placebo-controlled Trial

✍ Scribed by Black, Peter

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Everolimus for angiomyolipoma associated

✍ Bissler, John J; Kingswood, J Christopher; Radzikowska, Elżbieta; Zonnenberg, Be 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 286 KB

Re: Everolimus for Angiomyolipoma Associ

✍ Laguna, M. Pilar 📂 Article 📅 2014 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 58 KB

Efficacy and safety of everolimus for su

✍ Franz, David Neal; Belousova, Elena; Sparagana, Steven; Bebin, E Martina; Frost, 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 470 KB

Everolimus in Subependymal Giant Cell As

✍ M. Bebin; D.N. Franz; T. Sahmoud; E. Belousova; S. Sparagana; M. Frost; J. Ford; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 65 KB

The effect of everolimus on renal angiom

✍ Kingswood, J. C.; Jozwiak, S.; Belousova, E. D.; Frost, M. D.; Kuperman, R. A.; 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 499 KB